Michael M. Page
Perth, WA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Lipoprotein(a): Actionable today, treatable tomorrow?
Journal: Australian journal of general practice
Published: September 03, 2026
10-Year Trends in Lipoprotein(a) Testing in Queensland and Australia: A Retrospective Analysis of Ordering Patterns.
Journal: Heart, lung & circulation
Published: September 06, 2025
Plasma lipoprotein(a) is associated with calcification activity of the thoracic aorta and aortic valve in statin naïve individuals with diabetes mellitus.
Journal: European journal of clinical investigation
Published: November 10, 2023
Detecting patients with Cushing's syndrome: The importance of initial test selection.
Journal: Australian journal of general practice
Published: May 31, 2022
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemia.
Journal: Journal of clinical lipidology
Published: November 26, 2021
Approach to the diagnosis of secondary hypertension in adults.
Journal: Australian prescriber
Published: November 03, 2021
Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology.
Journal: Current opinion in cardiology
Published: March 20, 2021
Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New Zealand.
Journal: Journal of clinical apheresis
Published: May 09, 2020
Risk of undetected cases of gestational diabetes mellitus during the COVID-19 pandemic.
Journal: The Medical journal of Australia
Published: April 22, 2020
Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: March 21, 2020
Last Updated: 09/26/2026